| Literature DB >> 27436468 |
Ikbel Kooli1, Hajer Ben Brahim2, Mohamed Kilani3, Chokri Gannouni3, Abir Aouam2, Adnene Toumi2, Chawki Loussaief2, Mohamed Nejib Hattab3, Mohamed Chakroun2.
Abstract
Tigecycline is a broad-spectrum antibiotic with activity against multidrug-resistant (MDR) bacteria. It has limited indications. Studies are necessary to elaborate new guidelines. Here we report a case of postoperative MDR Acinetobacter baumannii meningitis treated by tigecycline combined with colimycin for 21 days. The treatment was well tolerated with a favourable outcome. In conclusion, tigecycline was shown to be effective in a case of MDR A. baumannii meningitis.Entities:
Keywords: Acinetobacter baumannii; Nosocomial meningitis; Tigecycline
Mesh:
Substances:
Year: 2015 PMID: 27436468 DOI: 10.1016/j.jgar.2015.12.003
Source DB: PubMed Journal: J Glob Antimicrob Resist ISSN: 2213-7165 Impact factor: 4.035